by Nabaparna Bhattacharya | Jan 27, 2026 | General
Maplebear Inc. (NASDAQ:CART), which operates as Instacart, saw its stock fall on Tuesday as Amazon.com, Inc. (NASDAQ:AMZN) expanded its grocery delivery footprint, heightening competitive pressure on Instacart despite the company’s newly announced retail...
by Henry Khederian | Jan 27, 2026 | General
Biomx Inc (AMEX:PHGE) shares are surging Tuesday afternoon following a 13D filing that disclosed Pyu Pyu Capital’s acquisition of a 19.99% stake in the company. Here’s what investors need to know. BiomX stock is charging ahead with explosive momentum. Why is PHGE...
by Vandana Singh | Jan 27, 2026 | General
Aclaris Therapeutics Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on immuno-inflammatory diseases, shared preclinical results from ATI-2138 in a murine model of severe alopecia areata (AA). Alopecia areata is an autoimmune disease that causes...
by Nabaparna Bhattacharya | Jan 27, 2026 | General
Affirm Holdings, Inc. (NASDAQ:AFRM) shares were initially up on Tuesday after the company announced a major buy-now, pay-later partnership, though the stock later pared some of those gains. • Affirm Holdings stock is trading in a tight range. What should traders watch...
by Vandana Singh | Jan 27, 2026 | General
The U.S. Food and Drug Administration (FDA) on Tuesday said it removed the clinical hold on Intellia Therapeutics Inc.‘s (NASDAQ:NTLA) Investigational New Drug application (IND) for the MAGNITUDE-2 Phase 3 trial of nexiguran ziclumeran (nex-z) for hereditary...
Recent Comments